These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 26846215

  • 1. Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study.
    Obradović J, Djordjević N, Tošic N, Mrdjanović J, Stanković B, Stanić J, Zarić B, Perin B, Pavlović S, Jurišić V.
    Tumour Biol; 2016 Aug; 37(8):10479-86. PubMed ID: 26846215
    [Abstract] [Full Text] [Related]

  • 2. Distribution of EGFR SNPs -191C/A and 181946G/A in patients with lung cancer depending on smoking status in the Republic of Srpska, Bosnia and Herzegovina.
    Elez-Burnjakovic N, Ugrin M, Obradovic J, Miletic N, Racic M, Kulic M, Pavlovic S, Jurisic V.
    J BUON; 2018 Aug; 23(2):384-390. PubMed ID: 29745081
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A study on the relationship between endoplasmic reticulum aminopeptidase2 genetic polymorphisms and non-small cell lung cancer in Yunnan Han population].
    Zhou J, Ma Q, Guo C, Shi L, Yao Y, Yu J, Zhang X.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):909-14. PubMed ID: 25609128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population.
    Hong S, Fang W, Hu Z, Zhou T, Yan Y, Qin T, Tang Y, Ma Y, Zhao Y, Xue C, Huang Y, Zhao H, Zhang L.
    Sci Rep; 2014 Dec 01; 4():7268. PubMed ID: 25434695
    [Abstract] [Full Text] [Related]

  • 8. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K.
    Lung Cancer; 2011 Aug 01; 73(2):138-46. PubMed ID: 21195504
    [Abstract] [Full Text] [Related]

  • 9. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH.
    Ai Zheng; 2005 Mar 01; 24(3):305-10. PubMed ID: 15757531
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
    Nomura M, Shigematsu H, Li L, Suzuki M, Takahashi T, Estess P, Siegelman M, Feng Z, Kato H, Marchetti A, Shay JW, Spitz MR, Wistuba II, Minna JD, Gazdar AF.
    PLoS Med; 2007 Apr 01; 4(4):e125. PubMed ID: 17455987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationship between genetic polymorphisms in MCP-1, CCR-2, and non-small-cell lung cancer in the Han nationality of Northern China.
    Yang L, Wang J, Li FG, Han M, Chang XJ, Wang ZT.
    Genet Mol Res; 2015 Apr 22; 14(2):3745-52. PubMed ID: 25966143
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers NL, Ratschiller D, Jermann M, Stahel RA, Heighway J, Betticher DC.
    Lung Cancer; 2006 Mar 22; 51(3):303-11. PubMed ID: 16406195
    [Abstract] [Full Text] [Related]

  • 15. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
    Gomes M, Coelho A, Araújo A, Teixeira AL, Catarino R, Medeiros R.
    Gene; 2012 Aug 01; 504(1):111-5. PubMed ID: 22583827
    [Abstract] [Full Text] [Related]

  • 16. Association between EGFR polymorphisms and the risk of lung cancer.
    Liu C, Xu X, Zhou Y.
    Int J Clin Exp Pathol; 2015 Aug 01; 8(11):15245-9. PubMed ID: 26823874
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH, Lee GW, Lee MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, Oh SY.
    Lung Cancer; 2012 Sep 01; 77(3):578-84. PubMed ID: 22608006
    [Abstract] [Full Text] [Related]

  • 18. The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation.
    Liu TC, Hsieh MJ, Liu MC, Chiang WL, Tsao TC, Yang SF.
    Int J Mol Sci; 2016 May 18; 17(5):. PubMed ID: 27213344
    [Abstract] [Full Text] [Related]

  • 19. Effects of DMSO, glycerol, betaine and their combinations in detecting single nucleotide polymorphisms of epidermal growth factor receptor (EGFR) gene promoter sequence in non-small-cell lung cancer (NSCLC) patients.
    Jurišić V, Obradović J, Tošić N, Pavlović S, Kulić M, Djordjević N.
    J Pharm Biomed Anal; 2016 Sep 05; 128():275-279. PubMed ID: 27284695
    [Abstract] [Full Text] [Related]

  • 20. Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.
    Kuo WH, Shih CM, Lin CW, Cheng WE, Chen SC, Chen W, Lee YL.
    Transl Res; 2012 Jan 05; 159(1):42-50. PubMed ID: 22153809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.